Litcius/Paper detail

Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists

Li Shen, Søren Lund Kristensen, Olof Bengtsson, Michael Böhm, Rudolf A. de Boer, Kieran F. Docherty, Silvio E. Inzucchi, Tzvetana Katova, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Daniel Lindholm, M. Felipe A. Martinez, Eileen O’Meara, José Carlos Nicolau, Mark C. Petrie, Piotr Ponikowski, Marc S. Sabatine, Morten Schou, Mikaela Sjöstrand, Scott D. Solomon, Pardeep S. Jhund, John J.V. McMurray

2021JACC Heart Failure125 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDapagliflozinMineralocorticoid receptorInternal medicineMineralocorticoidHeart failureAldosteroneEndocrinologyPharmacologyCardiologyDiabetes mellitusType 2 diabetesDiabetes Treatment and ManagementHormonal Regulation and HypertensionCardiovascular Function and Risk Factors